Wearable Evaluation of Ambulatory Readings for Blood Pressure
WEAR-BP
2 other identifiers
interventional
100
1 country
1
Brief Summary
The purpose of this project is to compare the performance and validity of novel wearable technologies that measure blood pressure (BP) and physical activity with a Spacelabs Ambulatory Blood Pressure Monitoring (ABPM) device.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 12, 2024
CompletedFirst Posted
Study publicly available on registry
September 24, 2024
CompletedStudy Start
First participant enrolled
June 6, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 3, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2026
ExpectedAugust 7, 2025
August 1, 2025
11 months
September 12, 2024
August 4, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Systolic Blood Pressure
Measured from all 5 randomized devices
24 - 48 hours
Secondary Outcomes (3)
Diastolic Blood Pressure
24 - 48 hours
Heart Rate
24 - 48 hours
ActivPaL device (Physical activity monitor)
24 - 48 hours
Other Outcomes (1)
Systolic blood pressure from the Biobeat device (Chest Patch Blood Pressure device)
24 hours
Study Arms (3)
Cuff-based ambulatory blood pressure monitor sequence
EXPERIMENTALParticipants will be randomized 1:1 to wear (A) the Spacelabs ambulatory blood pressure monitor on the first day and ABPMPro ambulatory blood pressure monitor on the second day or (B) ABPMPro ambulatory blood pressure monitor on the first day then Spacelabs ambulatory blood pressure monitor on the second day.
Left versus right upper limb
EXPERIMENTALParticipants will be randomized to wear the Aktiia cuffless blood pressure device on either the left upper limb versus the right upper limb on the first day. On the second day, the Aktiia blood pressure device will be switched to the other arm which did not get randomized on the first day. Another wristband (LiveMetric versus Bpro) will be worn on the contralateral arm.
Wristband sequence (first day versus second day)
EXPERIMENTALParticipants will be randomized 1:1 to wear (A) the LiveMetric wristband on the first day and Bpro wristband on the second day or (B) Bpro wristband on the first day then LiveMetric wristband on the second day. The arm side (i.e., right or left) will be determined by the Aktiia cuffless blood pressure device randomization on the first day. For the second day, the Aktiia cuffless blood pressure device will be worn on the arm opposite the first day with the other device (LiveMetric versus Bpro) worn on the contralateral arm.
Interventions
This is an upper arm, cuff-based intermittent ambulatory BP device. This device has an internal activity and body position sensor which gathers information about sleep-wake estimation.
This is an upper arm cuff-based device with tubing for continuous ambulatory BP monitoring with a unique activity sensor that correlate with patient movement activity with blood pressure changes.
This is a wrist cuff-based device which uses an optical sensor (photoplethysmography sensor) to gather data from the arteries under the skin surface. Aktiia has an upper arm cuff device which is used for calibration once every month to provide a baseline blood pressure reading.
This is a wrist cuff-based applanation tonometry continuous ambulatory BP device. This device has automatic self-calibration and comes in various sizes.
This is a wrist cuff-based wireless oscillometric, continuous ambulatory BP device. It has applanation tonometry at the wrist with Pulse wave analysis. This device needs calibration with a brachial cuff BP measurement.
Eligibility Criteria
You may qualify if:
- Age 18 to 100 years
- All neighborhoods in Boston area
- Be able to walk with two limbs and have two arms
- Willing and able to complete required measurement procedures
- Able to provide informed consent
You may not qualify if:
- Failure to receive informed consent
- Arm circumference of more than 50cm
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Stephen Jurascheklead
- National Institutes of Health (NIH)collaborator
- National Heart, Lung, and Blood Institute (NHLBI)collaborator
Study Sites (1)
Beth Israel Deaconess Medical Center
Boston, Massachusetts, 02215, United States
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
September 12, 2024
First Posted
September 24, 2024
Study Start
June 6, 2025
Primary Completion
May 3, 2026
Study Completion (Estimated)
June 30, 2026
Last Updated
August 7, 2025
Record last verified: 2025-08